Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $2.0089 per EA under NDC 00527409437. Its NADAC has been published 338 times since Mar 4, 2020.
FDA first approved this application on Dec 17, 2019. Its Orange Book therapeutic-equivalence code is AA.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE
butalbital, acetaminophen and caffeineStrength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Lannett Company Inc.NDC
00527409437
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA212083FDA Approved
12/17/2019
TE Code
AA
On Market Since
12/17/2019
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has been published 338 times since Mar 4, 2020, and over the history we have for it it has declined 42.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0089 per EA |
|---|---|
| All-time high | $3.5968 (Jun 10, 2020) |
| All-time low | $1.6931 (Jun 17, 2026) |
| 52-week high | $2.3000 |
| 52-week low | $1.6931 |
| Median price | $2.6767 |
| Average price | $2.7187 |
| Largest weekly change | +37.8% (Jun 19, 2024) |
| Weeks tracked | 338 |
| Tracking since | Mar 4, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Lannett Company Inc., is $2.0089 per EA (NDC 00527409437), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has declined 42.7%. It has been tracked across 338 weekly CMS publications since Mar 4, 2020.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
Since Mar 4, 2020, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $1.6931 (Jun 17, 2026) to a high of $3.5968 (Jun 10, 2020), with a median of $2.6767 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE, is $1.6931 per EA — about 16% below BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE (NDC 00527409437) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.